TIAA CREF Investment Management LLC lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 531,578 shares of the medical instruments supplier’s stock after selling 28,161 shares during the quarter. TIAA CREF Investment Management LLC owned about 0.23% of DENTSPLY SIRONA worth $34,468,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Commonwealth Bank of Australia increased its position in DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after acquiring an additional 260 shares in the last quarter. Dupont Capital Management Corp acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $116,000. Korea Investment CORP grew its position in shares of DENTSPLY SIRONA by 139.9% during the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares during the period. Sphera Funds Management LTD. acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $162,000. Finally, Penserra Capital Management LLC grew its position in shares of DENTSPLY SIRONA by 9.5% during the 1st quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the period. Hedge funds and other institutional investors own 93.87% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/22/tiaa-cref-investment-management-llc-lowers-holdings-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (XRAY) opened at 57.81 on Friday. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68. The firm’s market cap is $13.27 billion. The company’s 50-day moving average is $56.98 and its 200-day moving average is $61.67.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.65. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.76 EPS. On average, analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

Several brokerages have recently commented on XRAY. Jefferies Group LLC lowered their price target on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research report on Wednesday, August 23rd. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 14th. HC Wainwright reiterated a “buy” rating and set a $68.00 price target (down previously from $74.00) on shares of DENTSPLY SIRONA in a research report on Monday, August 14th. Finally, TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Three analysts have rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $65.73.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.